世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000034456

医療機器販売業務受託機関市場規模、シェア、動向分析レポート、およびセグメント予測2023 - 2030

Grand View Research Inc.

Healthcare Contract Sales Organizations Market Size, Share & Trends Analysis Report, And Segment Forecasts, 2023 - 2030

発刊日 2023/03

言語英語

体裁PDF/100ページ

ライセンス/価格100ページ

0000034456

Individual
Team
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

医療機器販売業務受託機関(CSO)市場の規模、シェア 、動向分析レポート:サービス別 (パーソナル プロモーション)、最終用途別 (製薬企業、バイオ医薬品企業)、地域別、およびセグメント予測、2023 ~ 2030

レポートの概要
世界の医療機器販売業務受託機関の市場規模は、2022 年に 119 億ドルと評価され、2023 年から 2030 年までに7.8% のCAGRで成長すると予想されます。医療機器販売業務受託機関市場は、さまざまな要因によって成長を遂げています。成長を促進する主な要因の 1 つは、新薬の上市数の増加と医薬品の研究開発活動の増加です。バイオ医薬品パイプラインも成長しており、パイプラインの全医薬品の 45% 以上がバイオ医薬品です。最後に、自社販売業務に伴うコストを削減する需要の増大も、受託販売サービスの採用を後押ししています。医療機器販売業務受託機関は、製薬会社が自社の販売チームを維持するための高いコストを負担することなく、製品を宣伝および販売するための費用対効果の高いソリューションを提供します。これら全ての要因が、医療機器 CSO 市場の成長を支えています。

レポート詳細

目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Service
1.1.2. End use
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
1.9.3. Objective 3
1.9.4. Objective 4

Chapter 2. Executive Summary
2.1. Market Outlook

Chapter 3. Healthcare Contract Sales Organizations Market (CSO) Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increase the R&D activities on drugs and increase in the drug pipeline
3.2.1.2. Growing interest of healthcare companies to increase the sales of the products
3.2.1.3. Adoption of digital technologies by Healthcare Contract Sales Organizations
3.2.2. Market restraint analysis
3.2.2.1. Quality issues associated with outsourcing
3.2.3. Covid-19 Impact & Recovery Analysis
3.2.4. Industry Analysis - Porter’s
3.2.5. PESTLE Analysis

Chapter 4. Healthcare Contract Sales Organizations Market (CSO): Service Segment Analysis
4.1. Healthcare Contract Sales Organizations Market (CSO) Market : Definition & Scope
4.2. Healthcare Contract Sales Organizations Market (CSO) Market : Service Market Share Analysis, 2022 & 2030
4.2.1. Personal Promotion
4.2.1.1. Personal promotion market, 2018 - 2030 (USD Million)
4.2.1.2. Promotional sales team
4.2.1.2.1. Promotional sales team market, 2018 - 2030 (USD Million)
4.2.1.3. Key account management
4.2.1.3.1. Key account management market, 2018 - 2030 (USD Million)
4.2.1.4. Vacancy Management
4.2.1.4.1. Vacancy Management market, 2018 - 2030 (USD Million)
4.2.2. Non-Personal Promotion
4.2.2.1. Non-Personal promotion market, 2018 - 2030 (USD Million)
4.2.2.2. Medical affairs solutions
4.2.2.2.1. Medical affairs solutions market, 2018 - 2030 (USD Million)
4.2.2.3. Remote medical science liaisons
4.2.2.3.1. Remote medical science liaisons market, 2018 - 2030 (USD Million)
4.2.2.4. Nurse (clinical) educators
4.2.2.4.1. Nurse (clinical) educators market, 2018 - 2030 (USD Million)
4.2.2.5. Others
4.2.2.5.1. Others market, 2018 - 2030 (USD Million)

Chapter 5. Healthcare Contract Sales Organizations Market (CSO): End-use Segment Analysis
5.1. Healthcare Contract Sales Organizations Market (CSO) Market : Definition & Scope
5.2. Healthcare Contract Sales Organizations Market (CSO) Market : End-use Market Share Analysis, 2022 & 2030
5.2.1. Pharmaceutical companies
5.2.1.1. Pharmaceutical companies Market, 2018 - 2030 (USD Million)
5.2.2. Biopharmaceutical companies
5.2.2.1. Biopharmaceutical companies Market, 2018 - 2030 (USD Million)
5.2.3. Medical device companies
5.2.3.1. Medical device companies Market, 2018 - 2030 (USD Million)

Chapter 6. Healthcare Contract Sales Organizations Market (CSO): Regional Analysis
6.1. Healthcare Contract Sales Organizations Market (CSO): Regional market share analysis, 2022 & 2030
6.2. North America
6.2.1. North America Market estimates and forecast, 2018 - 2030
6.2.2. U.S.
6.2.2.1. U.S. Market estimates and forecast, 2018 - 2030
6.2.3. Canada
6.2.3.1. Canada Market estimates and forecast, 2018 - 2030
6.3. Europe
6.3.1. Europe Market estimates and forecast, 2018 - 2030
6.3.2. U.K.
6.3.2.1. U.K. Market estimates and forecast, 2018 - 2030
6.3.3. Germany
6.3.3.1. Germany Market estimates and forecast, 2018 - 2030
6.3.4. France
6.3.4.1. France Market estimates and forecast, 2018 - 2030
6.3.5. Italy
6.3.5.1. Italy Market estimates and forecast, 2018 - 2030
6.3.6. Spain
6.3.6.1. Spain Market estimates and forecast, 2018 - 2030
6.3.7. Denmark
6.3.7.1. Denmark Market estimates and forecast, 2018 - 2030
6.3.8. Sweden
6.3.8.1. Sweden Market estimates and forecast, 2018 - 2030
6.3.9. Norway
6.3.9.1. Norway Market estimates and forecast, 2018 - 2030
6.4. Asia Pacific
6.4.1. Asia Pacific Market estimates and forecast, 2018 - 2030
6.4.2. Japan
6.4.2.1. Japan Market estimates and forecast, 2018 - 2030
6.4.3. China
6.4.3.1. China Market estimates and forecast, 2018 - 2030
6.4.4. India
6.4.4.1. India Market estimates and forecast, 2018 - 2030
6.4.5. South Korea
6.4.5.1. South Korea Market estimates and forecast, 2018 - 2030
6.4.6. Australia
6.4.6.1. Australia Market estimates and forecast, 2018 - 2030
6.4.7. Thailand
6.4.7.1. Thailand Market estimates and forecast, 2018 - 2030
6.5. Latin America
6.5.1. Latin America Market estimates and forecast, 2018 - 2030
6.5.2. Brazil
6.5.2.1. Brazil Market estimates and forecast, 2018 - 2030
6.5.3. Mexico
6.5.3.1. Mexico Market estimates and forecast, 2018 - 2030
6.5.4. Argentina
6.5.4.1. Argentina Market estimates and forecast, 2018 - 2030
6.6. `MEA
6.6.1. MEA Market estimates and forecast, 2018 - 2030
6.6.2. South Africa
6.6.2.1. South Africa Market estimates and forecast, 2018 - 2030
6.6.3. Saudi Arabia
6.6.3.1. Saudi Arabia Market estimates and forecast, 2018 - 2030
6.6.4. UAE
6.6.4.1. UAE Market estimates and forecast, 2018 - 2030
6.6.5. Kuwait
6.6.5.1. Kuwait Market estimates and forecast, 2018 - 2030

Chapter 7. Competitive Landscape
7.1. CMIC HOLDINGS Co., LTD
7.1.1. Company overview
7.1.2. Financial performance
7.1.3. Service benchmarking
7.1.4. Strategic initiatives
7.2. Axxelus
7.2.1. Company overview
7.2.2. Financial performance
7.2.3. Service benchmarking
7.2.4. Strategic initiatives
7.3. EPS Corporation.
7.3.1. Company overview
7.3.2. Financial performance
7.3.3. Service benchmarking
7.3.4. Strategic initiatives
7.4. QFR SOLUTIONS
7.4.1. Company overview
7.4.2. Financial performance
7.4.3. Service benchmarking
7.4.4. Strategic initiatives
7.5. MaBico
7.5.1. Company overview
7.5.2. Financial performance
7.5.3. Service benchmarking
7.5.4. Strategic initiatives
7.6. Mednext Pharma Private Limited
7.6.1. Company overview
7.6.2. Financial performance
7.6.3. Service benchmarking
7.6.4. Strategic initiatives
7.7. Peak Pharma Solutions Inc.
7.7.1. Company overview
7.7.2. Financial performance
7.7.3. Service benchmarking
7.7.4. Strategic initiatives
7.8. IQVIA, Inc.
7.8.1. Company overview
7.8.2. Financial performance
7.8.3. Service benchmarking
7.8.4. Strategic initiatives
7.9. Promoveo Health
7.9.1. Company overview
7.9.2. Financial performance
7.9.3. Service benchmarking
7.9.4. Strategic initiatives
7.10. Syneos Health
7.10.1. Company overview
7.10.2. Financial performance
7.10.3. Service benchmarking
7.11. Publicis Group
7.11.1. Company overview
7.11.2. Financial performance
7.11.3. Service benchmarking
7.11.4. Strategic initiatives
7.12. UDG Healthcare plc.
7.12.1. Company overview
7.12.2. Financial performance
7.12.3. Service benchmarking
7.12.4. Strategic initiatives

List of Tables
Table 1 List of secondary sources
Table 2 List of Abbreviations

List of Figures
Fig. 1 Market research process
Fig. 2 Information Procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain based sizing & forecasting
Fig. 6 QFD modelling for market share assessment
Fig. 7 Market segmentation & scope
Fig. 8 Healthcare CSO market outlook, 2018 - 2030
Fig. 9 Market trends & outlook
Fig. 10 Market driver relevance analysis (Current & future impact)
Fig. 11 Market restraint relevance analysis (Current & future impact)
Fig. 12 SWOT Analysis, By Factor (political & legal, economic and technological)
Fig. 13 Porter’s Five Forces Analysis
Fig. 14 Healthcare CSO market : Service outlook key takeaways
Fig. 15 Healthcare CSO market : Service movement analysis
Fig. 16 Personal Promotion market, 2018 - 2030 (USD Million)
Fig. 17 Promotional sales team-market, 2018 - 2030 (USD Million)
Fig. 18 Key account management market, 2018 - 2030 (USD Million)
Fig. 19 Vacancy management market, 2018 - 2030 (USD Million)
Fig. 20 Non - Personal Promotion market, 2018 - 2030 (USD Million)
Fig. 21 Medical affairs solutions market, 2018 - 2030 (USD Million)
Fig. 22 Remote medical science liaisons market, 2018 - 2030 (USD Million)
Fig. 23 Nurse (clinical) educators market, 2018 - 2030 (USD Million)
Fig. 24 Others market, 2018 - 2030 (USD Million)
Fig. 25 Healthcare CSO market:End use outlook key takeaways
Fig. 26 Healthcare CSO market:End use movement analysis
Fig. 27 Pharmaceutical companies market, 2018 - 2030 (USD Million)
Fig. 28 Biopharmaceutical companies market, 2018 - 2030 (USD Million)
Fig. 29 Regional market place: Key takeaway
Fig. 30 Healthcare CSO market regional outlook, 2020 & 2028
Fig. 31 North America Healthcare CSO market market, 2018 - 2030 (USD Million)
Fig. 32 U.S. Healthcare CSO market market, 2018 - 2030 (USD Million)
Fig. 33 Canada Healthcare CSO market market, 2018 - 2030 (USD Million)
Fig. 34 Europe Healthcare CSO market market, 2018 - 2030 (USD Million)
Fig. 35 Germany Healthcare CSO market market, 2018 - 2030 (USD Million)
Fig. 36 France Healthcare CSO market market, 2018 - 2030 (USD Million)
Fig. 37 U.K. Healthcare CSO market market, 2018 - 2030 (USD Million)
Fig. 38 Spain Healthcare CSO market market, 2018 - 2030 (USD Million)
Fig. 39 Italy Healthcare CSO market market, 2018 - 2030 (USD Million)
Fig. 40 Denmark Healthcare CSO market market, 2018 - 2030 (USD Million)
Fig. 41 Sweden Healthcare CSO market market, 2018 - 2030 (USD Million)
Fig. 42 Norway Healthcare CSO market market, 2018 - 2030 (USD Million)
Fig. 43 Asia Pacific Healthcare CSO market market, 2018 - 2030 (USD Million)
Fig. 44 Healthcare CSO market Healthcare CSO market market, 2018 - 2030 (USD Million)
Fig. 45 Japan Healthcare CSO market market, 2018 - 2030 (USD Million)
Fig. 46 India Healthcare CSO market market, 2018 - 2030 (USD Million)
Fig. 47 Thailand Healthcare CSO market market, 2018 - 2030 (USD Million)
Fig. 48 South Korea Healthcare CSO market market, 2018 - 2030 (USD Million)
Fig. 49 Australia Healthcare CSO market market, 2018 - 2030 (USD Million)
Fig. 50 Latin America Healthcare CSO market market, 2018 - 2030 (USD Million)
Fig. 51 Brazil Healthcare CSO market market, 2018 - 2030 (USD Million)
Fig. 52 Mexico Healthcare CSO market market, 2018 - 2030 (USD Million)
Fig. 53 Argentina Healthcare CSO market market, 2018 - 2030 (USD Million)
Fig. 54 Middle East & Africa Healthcare CSO market market, 2018 - 2030 (USD Million)
Fig. 55 South Africa Healthcare CSO market market, 2018 - 2030 (USD Million)
Fig. 56 Saudi Arabia Healthcare CSO market market, 2018 - 2030 (USD Million)
Fig. 57 UAE Healthcare CSO market market, 2018 - 2030 (USD Million)
Fig. 58 Kuwait Healthcare CSO market market, 2018 - 2030 (USD Million)

この商品のレポートナンバー

0000034456

TOP